It develops prosthetics and implants, wound dressings, and various surgical devices used in hospitals worldwide. In other words, Smith & Nephew is in the business of restoring people’s bodies.

wound dressings and other surgical aids, said it will likely take a tariff-related hit of $15 million to $20 million on its profit this year. Sign up here. While two-thirds of Smith+Nephew's U.S ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence ...

said Rohit Kashyap, President Advanced Wound Management at Smith+Nephew. “The ECRI ‘favorable’ rating for both our ALLEVYN LIFE Sacral Foam Dressing and LEAF Patient Monitoring System furthe ...

Smith & Nephew has been based in Hull since it was ... and a major new production line for foam dressings. Hull will also continue to be the home of the company’s global Advanced Wound ...

Smith & Nephew has announced it has revised plans ... and a major new production line for foam dressings. Hull will also continue to be the home of the company’s global Advanced Wound Management ...

Smith & Nephew has announced it has revised plans ... and a major new production line for foam dressings. Hull will also continue to be the home of the company's global Advanced Wound Management ...